Dermatology clinical trials recruiting in Texas

57 recruiting dermatology trials match in Texas. Showing 20.

• Flourish: Exploring the Early Infant Gut MicrobiomeRecruiting

  N/A · Seeding Inc · Austin, Texas

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)Recruiting

  Phase 4 · Eli Lilly and Company · Bellaire, Texas

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · Bellaire, Texas

• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruiting

  Phase 3 · Pfizer · Huntington Beach, California

• A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoRecruiting

  Phase 2 · Eli Lilly and Company · Humble, Texas

• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic DermatitisRecruiting

  Phase 2 · Galderma R&D · San Antonio, Texas

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Arlington, Texas

• A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoRecruiting

  Phase 1 · Teva Branded Pharmaceutical Products R&D LLC · Hot Springs, Arkansas

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · San Antonio, Texas

• A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)Recruiting

  Phase 2 / Phase 3 · Turn Therapeutics · Irving, Texas

• An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Frisco, Texas

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · San Antonio, Texas

• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRecruiting

  Phase 3 · AbbVie · Austin, Texas

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Houston, Texas

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Arlington, Texas

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Dallas, Texas

• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaRecruiting

  Phase 3 · Pfizer · San Antonio, Texas

• A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic ArthritisRecruiting

  Phase 2 · Novartis Pharmaceuticals · Colleyville, Texas

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · Janssen Research & Development, LLC · Frisco, Texas

• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental VitiligoRecruiting

  Phase 2 · Novartis Pharmaceuticals · Bellaire, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.